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Summary
Introduction
The prevalence of hepatitis C (HCV) infection in the 
general Italian population is between 1% and 3% in 
adults and up to 16% in elderly subjects (8-36%). Stud-
ies carried out in Italy during the ’90s showed viral 
replication in 54%-85% of subjects with anti-HCV 
antibodies according to the presence of HCV-RNA [1-
9]. The particular distribution by age of anti-HCV-posi-
tive subjects may be explained by a cohort effect. The 
high prevalence observed in the older population might 
represent the outcome of an epidemic that in Italy was 
particularly virulent between the ’50s and the early ’80s. 
Hepatitis C virus is mainly transmitted by the parenteral 
route through blood and blood products, so that in the 
past uncontrolled transfusions and medical procedures 
contributed to the spread of the disease [10, 11].
Recently, the use of intravenous drugs was found to be 
the major risk factor related to seroprevalence.
Since 1990, onward, utilization of new diagnostic tests, 
disposable medical devices, a better knowledge of ways 
of transmission, and the use of standard precautions 
in general medicine and in dentistry have dramatically 
reduced the incidence of the disease (from 5 to 0.5 per 
100,000 inhabitants in 2004) [12]. Infection is still as-
ymptomatic in 90% of cases. These data represent an 
underestimate of the actual number of new cases that 
may realistically range between 14 and 50 per 100,000 
person-year in the general population [13] and 2,4 per-
son-year in blood donors [14].
The vertical transmission seems to occur in 3-7% of cases 
in the presence of high viraemia and HIV co-infection in 
HCV-RNA positive women with known risk factors.
Maternal viremia represents the most important risk 
factor [15] even though the possible transmission from 
HCV-RNA negative mothers has been also reported in the 
literature [16, 17]. This might be attributed to the typical 
trend of chronic infections that may alternate blood clear-
ance phases to viremic phases. Concerning breast feeding 
and type of delivery, available data are uncertain [18].
In the present study we evaluated the prevalence of 
HCV infections in a general obstetric population of a 
northern Italian city and the incidence of vertical trans-
mission in the relative cohort of newborne. All women 
who delivered at the Gynaecologic and Obstetric Clinic 
of the Hospital of Parma from January 1st 1996 to De-
cember 31st 2001 was enrolled. In the study, follow-up 
of children born to HCV-positive mothers was carried 
out over 18-months after birth.
Methods
All women admitted at the Gynaecologic and Obstet-
ric Clinic of the Hospital of Parma for delivery from 
January 1st 1996 to December 31st 2001 underwent an 
anti-HCV antibody screening. Subject showing posi-
tive values were prospective enrolled in this 18 months 
follow-up with their children. All mothers gave the in-
formed consent to attend at the scheduled visits at time 
0, 3, 6, 10, and 18 months. Mothers and children were 
assessed for liver enzymes (ALT and AST), measure-
ment of antibodies (C100, HC-34, HCr-43, NS5) in the 
blood with a third generation ELISA test, ABBOTT 
HCV EIA 3.0®, followed by a RIBATM test (Ortho Chi-
ron RIBA HCV 3.0 SIA®) and tested for the presence 
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Introduction. Study reports of mother to child transmission of hep-
atitis C virus (HCV) have shown transmission rates ranging from 
3 to 37%, according to maternal viremia and HIV-1 coinfection. 
The present study evaluated the prevalence of the HCV infection in 
the general population and the incidence of vertical transmission, 
from women who delivered in the Obstetric Clinic of the Hospital 
of Parma from January 1st 1996 to 31st 2001 December.
Methods. Mothers and children were tested for the presence of 
HCV-RNA within one week after delivery. Children were consid-
ered to be infected when they were found positive at least twice 
for viral RNA or antibodies were still detectable at the end of 
the follow-up period (18 months) in blood.
Results. Out of 13,025 women, 110 (0.8%) were found positive 
for anti-HCV antibodies; 72 of them (65.4%) were HCV-RNA 
positive. All 110 children were positive for anti-HCV antibodies 
in the first blood sample (time 0); 8 of them were HCV-RNA posi-
tive. Three children were still viremic at the end of the follow-up 
whereas 5 showed a clearance. No significant differences were 
found between viremic and nonviremic children with respect 
to gestational week, maternal alanine aminotransferase (ALT) 
levels and newborns weight at birth.
Conclusion. This investigation shows that vertical transmis-
sion may occur in a general obstetric population despite a low 
prevalence of HCV-positive subjects.
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of HCV-RNA within one week from delivery. Viral 
nucleic acid extraction was performed with TRIZOL® 
(LIFE TECHNOLOGIES) followed by a qualitative 
RT-PCR with a sensitivity higher than 100 bp.
Nucleic acids were reverse transcripted into c-DNA 
and amplified by using specific nested primers from the 
most conserved 5’ untranslated region of the HCV virus 
genome. (For further details, see previously published 
notes) [19-21]. At the moment of enrollement, were col-
lected information about mother age at time of delivery, 
gestational week, type of delivery, newbornes’ weight, 
type of feed, history of past or recent drug addition, 
blood transfusions and occupation.
Type-specific primers were used for genotyping of viral 
RNA of the core region. In particular, cDNA was ampli-
fied with a universal primer (No 23, 467 to 486) to obtain 
a fragment of 285 bp. Such fragment was then amplified 
by specific primers for the genotypes 1a, 1b, 2 and 3a [22]. 
Children were considered to be infected (a) when they 
were positive for viral RNA at least twice or (b) if they 
did not became seronegative, showing demonstrable blood 
antibodies at the end of the follow-up period (18 months).
Statistical analysis: differences in frequencies were as-
sessed by the X2 Test, using the Fisher correction factor and 
T Student’s Test for variance analysis as appropriate.
Major risk factors were evaluated with a univariate 
model for the calculation of raw odds ratio, followed by 
a multivariate analysis by using the statistical software 
programme SPSS 12.0.
Results
Out of the 13,025 pregnant women delivered at the Gyn-
aecologic and Obstetric Clinic of the Hospital of Parma 
from January 1st 1996 to December 31st 2001 (mean/year: 
2,170) 110 (0.8%), showed detectable anti-HCV antibod-
ies. Seventy-two of them (65.4%) showed HCV-RNA.
The average age at the time of delivery was 32.2 years 
(range 20-41); 36.4% were primiparae (average age 
29.9 years). No statistically significant differences 
were observed between HCV viremic and nonviremic 
mothers for average age, ALT, gestational week, and 
newborns’ weight.
Histories of past or recent (during pregnancy) drug ad-
diction and blood transfusions were taken into account as 
possible risk factors related to mother’s viremia. None of 
these factors, assessed either individually or in correla-
tion, was found to be related to maternal viremia.
Jobs of 14.7% of women were associated with risk fac-
tors in the medical field (doctors, nurses, attendants). This 
factor was also unrelated to the viremic status. During the 
observational period, scalp electrodes were not frequently 
used; However, in view of the mother serologic status the 
use of scalp electrodes became contraindicated. Maternal 
feed was recommended in all children.
All 110 children showed anti-HCV antibodies in the 
first blood sample (time 0). In addition, eight of them, 
(all born by mothers with detectable HCV-RNA at de-
livery), were also found to be HCV-RNA positive in at 
least one test during the follow-up. Only two children 
were found HCV-RNA positive at time 0. Six children 
became HCV-RNA positive at second scheduled visit 
(3rd month of life).
Out of the 8 children, 3 were still viremic at the end of 
the follow-up period (2.7%), 3 RNA positive children in 
at least 1 blood sample, showed a clearance for HCV-
RNA at the end of the follow-up period, the remaining 
2 children abandoned the study after follow-up time 3 
when they became HCV-RNA negative. Concerning 
gestational week, maternal ALT and weight at birth, no 
significant differences were observed between viremic 
and nonviremic children.
One of the 3 children definitely infected was HIV posi-
tive. Concerning infant gender, a greater prevalence of 
females with respect to males was found (6 vs. 2 [OR 
2.7 IC95% 0.5-14.2]). No significant differences were 
found for type of delivery and type of feeding. In non-
viremic children, seroreversion was preferentially ob-
served in the 3rd or in the 4th blood samples (between 
the 6th and the 10th month of life).
The RNA identified in children and mothers was geno-
typed and compared. In the 72 viremic mothers group 
the most frequent genotype was the 1b (32%), followed 
by 3a (25%). The 2a genotype was identified in 4 moth-
ers and in their children, followed by the 1b genotype (2 
children) and by the 3a genotype (1 child), whereas one 
of the viruses could not be genotyped.
Discussion and conclusions
The data presented here agree with the results of a pre-
vious study performed in the early ’90s. In that study, 
the prevalence of HCV-positive women in the cohort of 
parturients was 1.3% with respect to the 0.8% preva-
lence detected in the present study. Therefore, in both 
studies, prevalence was within the lowest range of the 
overall prevalence in Italy [21].
The search for viral RNA in maternal blood was per-
formed in a sample taken within 1 week after delivery. 
This method provided reliable data concerning the viremic 
or nonviremic status of the mothers. According to recent 
studies [23] the percentage of HCV-RNA positive moth-
ers resulted to be high (65.45%). During the 5 years of 
investigation, 110 children born to HCV-positive mothers 
were monitored with the planned follow-up until their 18th 
month of life. Eight of them were found to be HCV-RNA 
positive, at least in one follow-up visit, but only two of 
them showed this condition at time 0. The hypothesis is 
that the delay observed could be associated to different 
timing in infection transmission (transplacental or perina-
tal route). Overall, the presence of viral RNA in at least 
one blood sample taken within a few weeks from delivery 
led the authors of the study to deem the actual occurrence 
of the vertical transmission. Therefore, the eight children 
were considered a homogeneous sample for statistical 
analysis. Females showed a higher (even though non sig-
nificant) prevalence (6 vs. 2); this observation is in agree-
ment with the reports of others [24]. One of the 3 infants 
with a positive status at the end of the follow-up period 
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positive. The mothers of the others two children who 
were still viremic (both with genotype 2a), did not differ 
in term of risk factors, but according to clinic special-
ists, their condition was classificated as “active chronic 
hepatitis C”. Two children abandoned the study after 2 
consecutive HCV-RNA negative tests; three children, 
who became HCV-RNA negative at time 4, were tested 
until the end of the follow-up and remained negative. 
These children did not show any clinical symptoms of 
infections during the scheduled follow-up visits; their 
transaminese tests were normal. Concerning maternal 
genotypes in agreement with other studies we observed 
the highest frequency of the 1b genotype, followed by 
the 3a genotype. In contrast in viremic children and in 
their mothers the 2a genotype was found to be the most 
frequent (4/8).
This investigation confirms that vertical transmission 
of hepatitis C virus infection may occur despite a low 
prevalence of HCV-positive subjects in a population 
of women in fertile age. The serologic tests, performed 
during pregnancy as screening, appear to be highly 
helpful to distinguish between women with or without 
risk factors. The major aim of the screening programs 
is represented by investigations of infants born to HCV 
positive mother [25] in order to establish appropriate 
treatments in an early stage of life.
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